World Congress on Controversies in Breast Cancer
The 3rd World Congress on Controversies in Breast Cancer invites medical oncologists, radiation oncologists, surgeons, pathologists, radiologists, nurses, students and residents to network with academics and clinicians from all over the world. Attendees will have the opportunity to partake in Q&A sessions with speakers after each presentation and to learn the latest in clinical recommendations for therapeutic dilemmas.
Congress chairpersons Bruce Mann, Seigo Nakamura, Javier Corte, Richard de Boer and Alastair Thompson welcome attendees to a ‘comprehensive congress dealing with controversial issues in breast cacner care including presentations, debates and discussions’.
Topics covered include:
- Neoadjuvant therapy
- Adjuvant endocrine therapy
- Molecular assays
- Triple negative breast cancer
- Endocrine resistance
- Her2 positive breast cancer
- Immunotherapy
- Breast imaging
- Breast cancer screening
- Local and locoregional therapy
- Imaging
- Bone health
- Breast reconstruction
- Breast cancer genetics
- Breast cancer 2022
You can follow the activity at this congress by searching the hashtag #CoBrCa. The official language of the congress is English but simultaneous Japanese interpretation will be available.